Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
MELINTA THERAPEUTICS, INC. /NEW/Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
MELINTA THERAPEUTICS, INC. /NEW/Listing unverified | Buy | $250K | conv 89ClusterFirst in 12mo | SEC | |
MELINTA THERAPEUTICS, INC. /NEW/Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
MELINTA THERAPEUTICS, INC. /NEW/Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
VALEANT PHARMACEUTICALS INTERNATIONALListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
VALEANT PHARMACEUTICALS INTERNATIONALListing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |